CSIMarket
 



Genocea Biosciences Inc   (GNCA)
Other Ticker:  
 



Genocea Biosciences Inc 's Debt Coverage ratios

GNCA's Debt and Ebitda growth


GNCA Debt Coverage (Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
Y / Y Total Debt Change -20.75 % -36.61 % -27.88 % -28.25 % -28.61 %
Y / Y Ebitda Change - - - - -
Debt Coverage (TTM) - - - - -
Total Ranking # # # # #
Seq. Total Debt Change -12.97 % -11.34 % 1.37 % 1.33 % -30.39 %
Seq. Ebitda Change - - - - -





Debt Coverage Ratio first quarter of 2022 Comment
Company recorded operating loss in the Q1 2022.

Within Healthcare sector Genocea Biosciences Inc achieved highest debt coverage ratio in the first quarter of 2022. While debt coverage ratio ranking remained unchanged in the Q1 2022 compared to the fourth quarter 2021 at no. .
Debt Coverage Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #


Debt Coverage Ratio Statistics
High Average Low
0 0 0
 



Financial Statements
Genocea Biosciences Inc 's Total Debt $ 8 Millions Visit GNCA's Balance sheet
Genocea Biosciences Inc 's Ebitda $ -15 Millions Visit GNCA's Income Statement
Where are GNCA's Sales coming from? Visit GNCA's Sales by Geography




Companies with similar Debt Coverage Mar 31 2022, within Healthcare Sector Debt Coverage
Date modified: 2023-03-25T04:00:08+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com